WallStSmart

CoStar Group Inc (CSGP)vsRafael Holdings, Inc. (RFL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CoStar Group Inc generates 293279% more annual revenue ($3.41B vs $1.16M). CSGP leads profitability with a 0.7% profit margin vs 0.0%. CSGP earns a higher WallStSmart Score of 54/100 (C-).

CSGP

Buy

54

out of 100

Grade: C-

Growth: 6.0Profit: 3.5Value: 7.3Quality: 8.0
Piotroski: 2/9Altman Z: 3.10

RFL

Avoid

30

out of 100

Grade: F

Growth: 8.0Profit: 2.5Value: 6.7Quality: 6.5
Piotroski: 3/9Altman Z: 0.44
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CSGPUndervalued (+89.2%)

Margin of Safety

+89.2%

Fair Value

$444.62

Current Price

$33.89

$410.73 discount

UndervaluedFair: $444.62Overvalued
RFLUndervalued (+54.5%)

Margin of Safety

+54.5%

Fair Value

$2.64

Current Price

$1.55

$1.09 discount

UndervaluedFair: $2.64Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CSGP5 strengths · Avg: 9.0/10
PEG RatioValuation
0.1210/10

Growing faster than its price suggests

Altman Z-ScoreHealth
3.1010/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
22.5%8/10

Revenue surging 22.5% year-over-year

RFL3 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
174.0%10/10

Revenue surging 174.0% year-over-year

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Areas to Watch

CSGP4 concerns · Avg: 3.0/10
Return on EquityProfitability
0.3%3/10

ROE of 0.3% — below average capital efficiency

Profit MarginProfitability
0.7%3/10

0.7% margin — thin

Operating MarginProfitability
0.3%3/10

Operating margin of 0.3%

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

RFL4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$92.58M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CSGP

The strongest argument for CSGP centers on PEG Ratio, Altman Z-Score, Debt/Equity. Revenue growth of 22.5% demonstrates continued momentum. PEG of 0.12 suggests the stock is reasonably priced for its growth.

Bull Case : RFL

The strongest argument for RFL centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 174.0% demonstrates continued momentum.

Bear Case : CSGP

The primary concerns for CSGP are Return on Equity, Profit Margin, Operating Margin. A P/E of 469.1x leaves little room for execution misses. Thin 0.7% margins leave little buffer for downturns.

Bear Case : RFL

The primary concerns for RFL are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

CSGP profiles as a growth stock while RFL is a hypergrowth play — different risk/reward profiles.

CSGP carries more volatility with a beta of 0.72 — expect wider price swings.

RFL is growing revenue faster at 174.0% — sustainability is the question.

CSGP generates stronger free cash flow (98M), providing more financial flexibility.

Bottom Line

CSGP scores higher overall (54/100 vs 30/100) and 22.5% revenue growth. RFL offers better value entry with a 54.5% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CoStar Group Inc

REAL ESTATE · REAL ESTATE SERVICES · USA

CoStar Group, Inc. provides online market information, analysis and services to the commercial real estate, hospitality, residential and related professional industries in the United States, Canada, Europe, Asia Pacific and Latin America. The company is headquartered in Washington, the District of Columbia.

Rafael Holdings, Inc.

REAL ESTATE · REAL ESTATE SERVICES · USA

Rafael Holdings, Inc. owns commercial real estate assets and interests in preclinical and clinical stage pharmaceutical companies. The company is headquartered in Newark, New Jersey.

Want to dig deeper into these stocks?